[Drug development in oncology. Its status and outlook with special consideration of the position of Germany].
Strohmeyer
T
T
Bristol Myers Squibb GmbH, München.
Weissbach
L
L
D000970:Antineoplastic Agents / Q000191:economics / Q000600:supply & distribution; D003365:Costs and Cost Analysis; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D005858:Germany; D006801:Humans; D012106:Research / Q000191:economics / Q000639:trends; D012307:Risk Factors
D000970:Antineoplastic Agents